BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3178171)

  • 1. Relationship between PRL levels and steroid receptors in breast cancer.
    Marugo M; Fazzuoli L; Bernasconi D; Berta S; Giordano G
    Anticancer Res; 1988; 8(4):819-23. PubMed ID: 3178171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of relationship between the levels of prolactin receptors and steroid receptors in women with breast cancer.
    Ben-David M; Wittliff JL; Fekete M; Kadar T; Biran S; Schally AV
    Biomed Pharmacother; 1988; 42(5):327-34. PubMed ID: 3191209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of estrogen and prolactin receptor analysis in human breast cancer.
    Waseda N; Kato Y; Imura H; Kurata M
    Jpn J Cancer Res; 1985 Jun; 76(6):517-23. PubMed ID: 2991064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid hormone receptors and response to high-dose medroxyprogesterone acetate in advanced breast cancer.
    Nomura Y; Tashiro H; Hisamatsu K; Shinozuka K
    Anticancer Res; 1988; 8(4):647-51. PubMed ID: 2972248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.
    Pujol P; Daures JP; Thezenas S; Guilleux F; Rouanet P; Grenier J
    Cancer; 1998 Aug; 83(4):698-705. PubMed ID: 9708933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of clone 4 estrogen receptor variant messenger RNA expression to some known prognostic variables in human breast cancer.
    Murphy LC; Hilsenbeck SG; Dotzlaw H; Fuqua SA
    Clin Cancer Res; 1995 Feb; 1(2):155-9. PubMed ID: 9815968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer.
    Thorpe SM; Rose C; Rasmussen BB; Mouridsen HT; Bayer T; Keiding N
    Cancer Res; 1987 Nov; 47(22):6126-33. PubMed ID: 3664512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical correlation of steroid receptors and disease-free interval in 206 consecutive cases of breast cancer: validation of telequantification based on global scene segmentation.
    Ferrer Roca OF; Ramos A; Diaz Cardama A
    Anal Cell Pathol; 1995 Sep; 9(2):151-63. PubMed ID: 7492518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of estrogen, progesterone and prolactin receptors in human breast cancer.
    Calandra RS; Charreau EH; Royer de Giaroli M; Baldi A
    Prog Clin Biol Res; 1984; 142():97-108. PubMed ID: 6709661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
    Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Overgaard J;
    J Clin Oncol; 2008 Mar; 26(9):1419-26. PubMed ID: 18285604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin binding in benign and malignant mammary tissue of female dogs.
    Rutteman GR; Willekes-Koolschijn N; Bevers MM; Van der Gugten AA; Misdorp W
    Anticancer Res; 1986; 6(4):829-35. PubMed ID: 3019223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
    Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
    J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
    Viale G; Regan MM; Maiorano E; Mastropasqua MG; Golouh R; Perin T; Brown RW; Kovács A; Pillay K; Ohlschlegel C; Braye S; Grigolato P; Rusca T; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
    J Clin Oncol; 2008 Mar; 26(9):1404-10. PubMed ID: 18349391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with prognosis in human breast cancer. IV. Progesterone receptors and clinical factors.
    Macías A; Pascual MR; Pérez R; Lage A
    Neoplasma; 1983; 30(5):593-601. PubMed ID: 6656963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between prolactin receptors (PRL R), estradiol (ER) and progesterone receptors (PgR) in human breast cancer.
    Bonneterre J; Peyrat JP; Beuscart R; Demaille A
    Eur J Cancer Clin Oncol; 1986 Nov; 22(11):1331-6. PubMed ID: 3830215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
    Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
    Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of steroid receptors and DNA synthesis in male breast cancer].
    Petroni S; Mangia A; D'Amico C; Simone G
    Pathologica; 2003 Feb; 95(1):31-6. PubMed ID: 12735283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte reactivity to mitogens and tumor sex steroid receptors in breast cancer patients.
    Kastelan M; Rudolf M; Hrsak M; Stojkovic R; Gamulin S
    Biomed Pharmacother; 1985; 39(8):442-4. PubMed ID: 3834952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.